Medical/Pharmaceuticals

Perkbox reimagines global reward and benefits for the post-pandemic world

LONDON, Aug. 18, 2021 /PRNewswire/ -- Perkbox , the global benefits and reward platform, today announces its new offering to help employers care for, connect with, and celebrate their people around the world. The new location agnostic Perkbox platform enables employers...

2021-08-18 15:00 1868

H3C Joins Hands with Medical Corporation Sapporo Heart Center, Sapporo Cardio Vascular Clinic: Reshaping Digital Architecture to Embrace Smart Healthcare

SAPPORO, Japan, Aug. 18, 2021 /PRNewswire/ -- As one of the countries with the longest life expectancy in the world, the health of Japanese comes not only from good living habits, but also from high-quality medical services. Founded in 2008, Medical Corporation Sapporo Heart Center, Sapporo Cardi...

2021-08-18 11:11 1908

COVID-19 CARE Assist & Employer Tracking Programme Launched by DoctorOnCall

KUALA LUMPUR, Malaysia, Aug. 18, 2021 /PRNewswire/ -- DoctorOnCall, Malaysia's first and largest digital health platform today announced the launch of the DoctorOnCall Covid-19 CARE Assist programme for all purchasers of the Rapid Antigen (RTK-Ag) Self-Test kits. This benefit is available to A...

2021-08-18 10:00 2561

Significant Weight Loss and Multiple Metabolic Benefits: Phase 1b Study Results of IBI362 in Chinese Participants with Overweight or Obesity Published in EClinicalMedicine by the Lancet

SAN FRANCISCO and SUZHOU, China, Aug. 18, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major dise...

2021-08-18 08:00 3569

Transcenta Held Investigator Meeting and Initiated Phase IIa Clinical Trial of Claudin18.2 Monoclonal Antibody TST001 with First Patient Dosed Successfully

SUZHOU, China, Aug. 18, 2021 /PRNewswire/ -- Transcenta announced that it held an investigator meeting successfully for TST001 Phase I clinical trial study on August 14. Professors Lin Shen and Jifang Gong from Beijing Cancer Hospital, ProfessorWeijian Guo from Fudan University Shanghai Cancer Cen...

2021-08-18 08:00 1968

PT Anugerah Pharmindo Lestari (APL) Won 'Community Initiative' Award and 'Outstanding Leader in Asia' Title for Its President Director at the Asia Corporate Excellence & Sustainability Awards 2021

JAKARTA, Indonesia, Aug. 17, 2021 /PRNewswire/ -- PT Anugerah Pharmindo Lestari (APL), a member of Zuellig Pharma, a leading healthcare services company in Indonesia, has been awarded with the 'Community Initiative' and 'Outstanding Leader inAsia' for APL's President Director, Christophe Piganiol,...

2021-08-17 22:02 2036

MediTrust Health Raises Over RMB2 Billion in Series C Financing Successfully: ESG Drives Value Creation

HONG KONG, Aug. 17, 2021 /PRNewswire/ -- Shanghai MediTrust Health Technology Co., Ltd. (hereinafter referred to as "MediTrust"), a leading innovative healthcare services platform inChina, announced a successful capital raising of overRMB2 billion (approximately US$308 million) in a Series C fina...

2021-08-17 19:47 1459

Innoforce Pharmaceuticals Opens Analytical Development and Process Development Facility in Hangzhou, China

HANGZHOU, China and ROCKVILLE, Md., Aug. 17, 2021 /PRNewswire/ -- Innoforce Pharmaceuticals ("Innoforce"), a biopharmaceutical innovation and partnership company, today announces that it has opened a new Advanced Cell and Gene Therapy Development Facility inHangzhou, China. Analytical development...

2021-08-17 19:00 1501

SINOMED announces the first commercial implantation and European launch of the HT Supreme Drug Eluting Stent

TIANJIN, China, Aug. 17, 2021 /PRNewswire/ -- SINOMED, a leading international medical device company, announced the first commercial implantation of the HT Supreme® Drug-Eluting Stent (DES) at University Hospital Galway in partnership with theNational University of Ireland Galway (NUI Galway), m...

2021-08-17 18:00 1822

MILVIK Launches COVID-19 Insurance and Telemedicine Bundle in Bangladesh

DHAKA, Bangladesh, Aug. 17, 2021 /PRNewswire/ -- Global healthcare and insurtech providerMILVIK today announces the launch of its dedicated COVID-19 bundle to consumers inBangladesh. 10-year-old MILVIK (glo...

2021-08-17 10:00 2594

Under the Patronage of His Highness Sheikh Theyab bin Mohamed bin Zayed Al Nahyan, Abu Dhabi Early Childhood Authority's WED Movement Engages Global Experts to Drive Innovation, Excellence in Early Childhood Development

ABU DHABI, UAE, Aug. 17, 2021 /PRNewswire/ -- Abu Dhabi's World Early Childhood Development Movement (WED Movement) has launched a new initiative bringing together global experts to develop innovative and actionable solutions advancing Abu Dhabi's vision to be a leader in Early Childhood Developme...

2021-08-17 00:51 3126

Tikomed's ILB® attenuates clinical symptoms and serum biomarkers of oxidative/nitrosative stress and mitochondrial dysfunction in ALS patients, data published by the Journal of Personalized Medicine

VIKEN, Sweden, Aug. 16, 2021 /PRNewswire/ -- New study results for Tikomed's platform lead drug candidate ILB® in the treatment of patients with amyotrophic lateral sclerosis (ALS), have now been published in the Journal of Personalized Medicine. The data revealed a significant normalization of t...

2021-08-16 22:32 1407

InferVision AI Assists the European Commission Monitoring COVID-19 Variants

WIESBADEN, Germany, Aug. 16, 2021 /PRNewswire/ -- InferVision AI has been selected to help monitor COVID-19 variants across the European Union. Faced with this challenge, the European Commission decided to increase their investment in the adoption of AI tools from InferVision. InferVision's AI to...

2021-08-16 21:51 2941

Ascletis' Partner Sagimet Dosed First Patient in FASCINATE-2 Phase IIb Trial in NASH Patients with Moderate to Advanced Fibrosis

HANGZHOU and SHAOXING, China, Aug. 16, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672) today announces that its partner Sagimet Biosciences dosed the first patient in its FASCINATE-2 Phase IIb clinical trial for non-alcoholic steatohepatitis (NASH). FASCINATE-2 is a randomized, double-blin...

2021-08-16 21:30 2596

BioAgilytix to Purchase Australia-based 360biolabs®

Highly complementary transaction will strengthen company's ability to support bioanalytical services across all stages, development capabilities and geographies DURHAM, N.C., Aug. 16, 2021 /PRNewswire/ -- BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research laboratory focused ...

2021-08-16 18:00 2533

Introducing ProXmask(TM): Antiviral Face Mask as Better Alternative to Double-Masking and Capable of Inactivate SARS-CoV-2

KUALA LUMPUR, Malaysia, Aug. 16, 2021 /PRNewswire/ -- ProXmask™ is the first antiviral face mask mass-produced in theAsia Pacific by Prolexus Group. The antiviral face mask created by Prolexus Group is a remarkable example of conventional OEM (original equipment manufacturer) for globally renowne...

2021-08-16 15:21 2355

Occlutech granted important conditional FDA approval for PFO Study (OCCLUFLEX) in the U.S.

SCHAFFHAUSEN, Switzerland, Aug. 16, 2021 /PRNewswire/ -- Occlutech Holding AG ("Occlutech"), one of the world´s leading providers of minimally invasive structural heart disease devices, announces the conditional U.S. Food and Drug Administration ("FDA") approval of its Investigational Device Exem...

2021-08-16 14:00 1669

Sino Biological Announces Successful Closing of 4.98 Billion RMB Public Offering and Listing on the Shenzhen ChiNext Stock Exchange

BEIJING, Aug. 16, 2021 /PRNewswire/ -- Sino Biological, Inc. ("Sino Biological" or the "Company"), a biotechnology company which provides biological research reagents and related technical contract research services, announced a successful listing on the Shenzhen Stock Exchange subsidiary ChiNext...

2021-08-16 13:12 2527

Innovent Announces Sintilimab in Combination with Chemotherapy Meets the Primary Endpoint of Overall Survival in the Phase 3 ORIENT-16 Study for the First-Line Treatment of Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

SAN FRANCISCO and SUZHOU, China, Aug. 16, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...

2021-08-16 08:00 5894

RenalSense Announces Distribution Agreement in Mainland China with Gloryway

JERUSALEM and BEIJING, Aug. 16, 2021 /PRNewswire/ -- RenalSense™, an Israeli company specializing in real-time renal diagnostics, today announced a distribution agreement with Gloryway, a leading distributor in mainlandChina of medical devices in anesthesia, airway management, temperature managem...

2021-08-16 08:00 1959
1 ... 221222223224225226227 ... 382